Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Improvement of Efficacy Outcomes in Patients Who Switched from Sucrose-Formulated rFVIII to BAY 81-8973 Prophylaxis in the LEOPOLD Clinical Trials

Gili Kenet, Thomas Moulton, MD, Erika Soltes Rak, Brian M. Wicklund, MDMPH, Sanjay P Ahuja, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-137532

Published: 2020

Journal Articles

Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII

Mark Reding, MD, Thomas Moulton, MD, Erika Soltes Rak, Mindy L Simpson, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-137565

Published: 2020

Journal Articles

A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients

Jennifer Alison Busse, CNP, MPH, Kranthi Nandan Seelaboyina, MBBS, Grace Malonga, MPH, Thomas Moulton, MD

Blood (2013) 122 (21): 1723.

https://doi.org/10.1182/blood.V122.21.1723.1723

Published: 2013

Journal Articles

Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients

Jennifer Alison Busse, CNP, MPH, Kranthi Nandan Seelaboyina, MBBS, Grace Malonga, MPH, Madhuri Jakkam Setty, MBBS, Thomas Moulton, MD

Blood (2013) 122 (21): 4677.

https://doi.org/10.1182/blood.V122.21.4677.4677

Published: 2013

Journal Articles

A Novel β Globin Gene Mutation, Reported As An α Chain Hemoglobin Variant By High Performance Liquid Chromatography (HPLC) & As Sickle Cell Trait On New Born Screening: A case Report

Kranthi Nandan Seelaboyina, MBBS, Jennifer Alison Busse, CNP, MPH, Sandeep Malik, MD, Thomas Moulton, MD

Blood (2013) 122 (21): 954.

https://doi.org/10.1182/blood.V122.21.954.954

Published: 2013

Journal Articles

Non-Invasive Urinary Markers of Renal Dysfunction in Sickle Cell Disease.

Davoud Mohtat, MD, Thomas Moulton, MD, M. Catherine Driscoll, MD, Robert P Woroniecki, MD

Blood (2009) 114 (22): 4621.

https://doi.org/10.1182/blood.V114.22.4621.4621

Published: 2009

NARROW

Improvement of Efficacy Outcomes in Patients Who Switched from Sucrose-Formulated rFVIII to BAY 81-8973 Prophylaxis in the LEOPOLD Clinical Trials

Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII

A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients

Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients

A Novel β Globin Gene Mutation, Reported As An α Chain Hemoglobin Variant By High Performance Liquid Chromatography (HPLC) & As Sickle Cell Trait On New Born Screening: A case Report

Non-Invasive Urinary Markers of Renal Dysfunction in Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Improvement of Efficacy Outcomes in Patients Who Switched from Sucrose-Formulated rFVIII to BAY 81-8973 Prophylaxis in the LEOPOLD Clinical Trials

Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII

A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients

Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients

A Novel β Globin Gene Mutation, Reported As An α Chain Hemoglobin Variant By High Performance Liquid Chromatography (HPLC) & As Sickle Cell Trait On New Born Screening: A case Report

Non-Invasive Urinary Markers of Renal Dysfunction in Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only